Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.23B.
ENTERPRISE VALUE (EV)
$1.23B
AnaptysBio, Inc.
Market Cap
$1.46B
Enterprise Value (EV)
$1.23B
Market Cap
$1.43B
Enterprise Value (EV)
$1.19B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| AnaptysBio, Inc. (ANAB) | $1.46B | $1.23B |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | $1.31B |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | $1.19B |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | $1.18B |
| Innoviva, Inc. (INVA)vs › | $1.52B | $1.22B |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | $1.53B |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | $1.26B |
| Certara, Inc. (CERT)vs › | $1.57B | $1.67B |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.34B | $1.34B |
Market Cap
$1.46B
Total Debt
$12.03M
Cash
$238.20M
Enterprise Value
$1.23B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
